Terms: = Germ cell tumor AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2
291 results:
1. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
[TBL] [Abstract] [Full Text] [Related]
2. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological analysis of rosette-forming glioneuronal tumors.
Liu J; Lin F; Sun Y; Liu X
Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
[TBL] [Abstract] [Full Text] [Related]
4. Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.
Radin DP; Shifman S; Outhwaite IR; Sharma A; Bases R; Seeliger MA; Tsirka SE
J Pharmacol Exp Ther; 2024 Mar; 389(1):51-60. PubMed ID: 38296645
[TBL] [Abstract] [Full Text] [Related]
5. Utility of combining olig2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract] [Full Text] [Related]
6. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
[TBL] [Abstract] [Full Text] [Related]
7. MRI characteristics of H3 G34-mutant diffuse hemispheric gliomas and possible differentiation from IDH-wild-type glioblastomas in adolescents and young adults.
Shao H; Gong J; Su X; Chen N; Li S; Yang X; Zhang S; Huang Z; Hu W; Gong Q; Liu Y; Yue Q
J Neurosurg Pediatr; 2024 Mar; 33(3):236-244. PubMed ID: 38157540
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
9. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
10. Glioblastoma/high-grade glioma with a primitive neuronal component including rhabdoid differentiation that was difficult to diagnose: A case report.
Kumagai M; Takata S; Watanabe T; Shioya A; Han J; Shimasaki M; Ueda Y; Hayashi Y; Yamada S
Pathol Res Pract; 2023 Nov; 251():154830. PubMed ID: 37890269
[TBL] [Abstract] [Full Text] [Related]
11. Strong olig2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.
de Castro JVA; Kulikowski LD; Wolff BM; Natalino R; Carraro DM; Torrezan GT; Scapulatempo Neto C; Amancio CT; Canedo FSNA; Feher O; Costa FD
Neuropathology; 2024 Apr; 44(2):167-172. PubMed ID: 37855183
[TBL] [Abstract] [Full Text] [Related]
12. Glioma with cribriform plate involvement in 6 dogs.
Reyes VAA; Howerth EW; Blas-Machado U; Platt SR; Pavarini SP; Castro LT; Church ME; Rissi DR
J Vet Diagn Invest; 2023 Nov; 35(6):800-805. PubMed ID: 37608783
[TBL] [Abstract] [Full Text] [Related]
13. Primary and secondary leptomeningeal gliomatosis in dogs.
Rissi DR; Reyes VAA; Donovan TA; Church ME; Howerth EW; Klang A; Woolard KD; Miller AD
Vet Pathol; 2024 Mar; 61(2):171-178. PubMed ID: 37577961
[TBL] [Abstract] [Full Text] [Related]
14. Deciphering the Action of Neuraminidase in Glioblastoma Models.
Baeza-Kallee N; Bergès R; Hein V; Cabaret S; Garcia J; Gros A; Tabouret E; Tchoghandjian A; Colin C; Figarella-Branger D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511403
[TBL] [Abstract] [Full Text] [Related]
15. Distinct retinoic gene signatures discriminate Merkel cell polyomavirus-positive from -negative Merkel cell carcinoma cells.
Mazziotta C; Cervellera CF; Badiale G; Vitali I; Touzé A; Tognon M; Martini F; Rotondo JC
J Med Virol; 2023 Jul; 95(7):e28949. PubMed ID: 37436928
[TBL] [Abstract] [Full Text] [Related]
16. A diffuse glioma with oligodendroglial-like cells and extensive calcifications.
Martelli FM; Marastoni E; Barresi V
Brain Pathol; 2024 Jan; 34(1):e13187. PubMed ID: 37409721
[TBL] [Abstract] [Full Text] [Related]
17. Oligodendrocyte Transcription Factor 2 as a Potential Prognostic Biomarker of Glioblastoma: Kaplan-Meier Analysis and the Development of a Binary Predictive Model Based on Visually Accessible Rembrandt Image and Magnetic Resonance Imaging Radiomic Features.
Mei N; Lu Y; Yang S; Jiang S; Ruan Z; Wang D; Liu X; Ying Y; Li X; Yin B
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):650-658. PubMed ID: 37380154
[TBL] [Abstract] [Full Text] [Related]
18. Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.
Reisz Z; Radics BL; Nemes P; Laxton R; Kaizer L; Gabor KM; Novak T; Barzo P; Al-Sarraj S; Bodi I
Pathol Oncol Res; 2023; 29():1611231. PubMed ID: 37362245
[No Abstract] [Full Text] [Related]
19. The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
Dénes A; Bontell TO; Barchéus H; Vega SF; Carén H; Lindskog C; Jakola AS; Smits A
PLoS One; 2023; 18(5):e0285732. PubMed ID: 37192181
[TBL] [Abstract] [Full Text] [Related]
20. olig2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W
Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387
[TBL] [Abstract] [Full Text] [Related]
[Next]
